Cargando…

Insulin-Like Growth Factor-1 Down-Regulates the Phosphorylation of FXYD1 and Rescues Behavioral Deficits in a Mouse Model of Rett Syndrome

Rett syndrome (RTT) is a neurodevelopmental disease in children that is mainly caused by mutations in the MeCP2 gene, which codes for a transcriptional regulator. The expression of insulin-like growth factor-1 (IGF-1) is reduced in RTT patients and animal models, and IGF-1 treatment is a promising t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Zhe-Feng, Mao, Shan-Shan, Shen, Jue, Jiang, Li-Hua, Xu, Lu, Xu, Jia-Lu, Gao, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000522/ https://www.ncbi.nlm.nih.gov/pubmed/32063830 http://dx.doi.org/10.3389/fnins.2020.00020

Ejemplares similares

Choline Rescues Behavioural Deficits in a Mouse Model of Rett Syndrome by Modulating Neuronal Plasticity
por: Chin, Eunice W. M., et al.
Publicado: (2018)

FXYD6 promotes thermal nociception by regulating TRPV1
por: Luo, Hao, et al.
Publicado: (2021)

Impaired AQP2 trafficking in Fxyd1 knockout mice: A role for FXYD1 in regulated vesicular transport
por: Arystarkhova, Elena, et al.
Publicado: (2017)

What FXYDs fix
por: Habeck, Michael, et al.
Publicado: (2021)

MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome
por: Tai, Derek J. C., et al.
Publicado: (2016)

Novel DYRK1A Inhibitor Rescues Learning and Memory Deficits in a Mouse Model of Down Syndrome
por: Stensen, Wenche, et al.
Publicado: (2021)

Rescue of deficits by Brwd1 copy number restoration in the Ts65Dn mouse model of Down syndrome
por: Fulton, Sasha L., et al.
Publicado: (2022)

Anti-Semaphorin 4D Rescues Motor, Cognitive, and Respiratory Phenotypes in a Rett Syndrome Mouse Model
por: Mao, Yilin, et al.
Publicado: (2021)

Expression and Significance of FXYD-3 Protein in Gastric Adenocarcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2010)

Expression and clinical significance of FXYD3 in endometrial cancer
por: LI, YIFEI, et al.
Publicado: (2014)

FXYD-3 expression in relation to local recurrence of rectal cancer
por: Loftas, Per, et al.
Publicado: (2016)

Epigenetic remodelling of Fxyd1 promoters in developing heart and brain tissues
por: Cuomo, Mariella, et al.
Publicado: (2022)

Displacement of Native FXYD Protein From Na(+)/K(+)-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
por: Liu, Chia-Chi, et al.
Publicado: (2022)

FXYD6 is a new biomarker of cholangiocarcinoma
por: CHEN, XIONGFEI, et al.
Publicado: (2014)

FXYD proteins and sodium pump regulatory mechanisms
por: Yap, John Q., et al.
Publicado: (2021)

Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation
por: Urbinati, Chiara, et al.
Publicado: (2021)

Insulin-like growth factor-1 rescues synaptic and motor deficits in a mouse model of autism and developmental delay
por: Bozdagi, Ozlem, et al.
Publicado: (2013)

Dietary rescue of adult behavioral deficits in the Fmr1 knockout mouse
por: Nolan, Suzanne O., et al.
Publicado: (2022)

Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome
por: Martinez de Lagran, Maria, et al.
Publicado: (2022)

FXYD6: a novel therapeutic target toward hepatocellular carcinoma
por: Gao, Qian, et al.
Publicado: (2014)

Restoration of Mecp2 expression in GABAergic neurons is sufficient to rescue multiple disease features in a mouse model of Rett syndrome
por: Ure, Kerstin, et al.
Publicado: (2016)

Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome
por: Parrini, Martina, et al.
Publicado: (2021)

Prognostic significance of sodium-potassium ATPase regulator, FXYD3, in human hepatocellular carcinoma
por: Wang, Li-Juan, et al.
Publicado: (2018)

VPA Alleviates Neurological Deficits and Restores Gene Expression in a Mouse Model of Rett Syndrome
por: Guo, Weixiang, et al.
Publicado: (2014)

FXYD3: A Promising Biomarker for Urothelial Carcinoma
por: Zhang, ZhongFa, et al.
Publicado: (2011)

Overexpression of FXYD-3 Is Involved in the Tumorigenesis and Development of Esophageal Squamous Cell Carcinoma
por: Zhu, Zhen-Long, et al.
Publicado: (2013)

Effect of differentiation, de novo innervation, and electrical pulse stimulation on mRNA and protein expression of Na(+),K(+)-ATPase, FXYD1, and FXYD5 in cultured human skeletal muscle cells
por: Jan, Vid, et al.
Publicado: (2021)

Wild type microglia arrest pathology in a mouse model of Rett syndrome
por: Derecki, Noël C., et al.
Publicado: (2012)

Gene therapy using human FMRP isoforms driven by the human FMR1 promoter rescues fragile X syndrome mouse deficits
por: Jiang, Yiru, et al.
Publicado: (2022)

FXYD5: Na(+)/K(+)-ATPase Regulator in Health and Disease
por: Lubarski Gotliv, Irina
Publicado: (2016)

FXYD6 overexpression in HBV-related hepatocellular carcinoma with cirrhosis
por: Chen, Xiongfei, et al.
Publicado: (2020)

Forniceal deep brain stimulation rescues hippocampal memory in Rett syndrome mice
por: Hao, Shuang, et al.
Publicado: (2015)

Rett and Rett‐like syndrome: Expanding the genetic spectrum to KIF1A and GRIN1 gene
por: Wang, Jiaping, et al.
Publicado: (2019)

Beneficial Renal and Pancreatic Phenotypes in a Mouse Deficient in FXYD2 Regulatory Subunit of Na,K-ATPase
por: Arystarkhova, Elena
Publicado: (2016)

Cellular Origins of Auditory Event-Related Potential Deficits in Rett Syndrome
por: Goffin, Darren, et al.
Publicado: (2014)

Missense variants in ATP1A3 and FXYD gene family are associated with childhood-onset schizophrenia
por: Chaumette, Boris, et al.
Publicado: (2018)

Radically truncated MeCP2 rescues Rett syndrome-like neurological defects
por: Tillotson, Rebekah, et al.
Publicado: (2017)

FXYD5 Is an Essential Mediator of the Inflammatory Response during Lung Injury
por: Brazee, Patricia L., et al.
Publicado: (2017)

Expression mode and prognostic value of FXYD family members in colon cancer
por: Jin, Ming, et al.
Publicado: (2021)

FXYD6 Regulates Chemosensitivity by Mediating the Expression of Na+/K+-ATPase α1 and Affecting Cell Autophagy and Apoptosis in Colorectal Cancer
por: Luo, Wen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7v3nj2b7drt4rdh9lnm2su0v3n